Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Juliette Eroukhmanoff, Frederic Castinetti, Nicolas Penel, Sebastien Salas

ABSTRACT

BACKGROUND: While hypothyroidism has frequently been reported with the use of TKIs, the thyroid-stimulating hormone (TSH) suppressing effect of TKIs is rare, except for thyroiditis. We describe a case with progressive recurrent chordoma who initially became hyperthyroid in a context of autoimmunity under sorafenib treatment and later under imatinib treatment. CASE PRESENTATION: A 57-year-old man with lumbar chordoma began daily treatment of 800 mg sorafenib. He did not have any other medication or recent iodinated-contrast exposure and his family history was negative for thyroid and autoimmune disease. There was no history of neck pain, irradiation or trauma, recent fever or viral illness. Pre-treatment TSH was normal. After 18 weeks of treatment, the patient presented hyperthyroidism with positive anti-TSH receptor antibodies. More surprisingly, Graves' disease recurred during treatment with imatinib. CONCLUSION: The fact that Graves' disease occurred after two different TKIs suggests that it could be a rare but important class effect. Anti-TSH receptor antibodies should be systematically measured when TSH decreases in order to avoid the erroneous diagnosis of transient hyperthyroidism due to thyroiditis. More... »

PAGES

679

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3

DOI

http://dx.doi.org/10.1186/s12885-016-2705-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010473172

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27558389


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chordoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graves Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imatinib Mesylate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Niacinamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sorafenib", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "H\u00f4pital de la Conception", 
          "id": "https://www.grid.ac/institutes/grid.411535.7", 
          "name": [
            "Department of Medicine, Division of endocrinology, APHM, Conception Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eroukhmanoff", 
        "givenName": "Juliette", 
        "id": "sg:person.016217422035.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016217422035.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital de la Conception", 
          "id": "https://www.grid.ac/institutes/grid.411535.7", 
          "name": [
            "Department of Medicine, Division of endocrinology, APHM, Conception Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castinetti", 
        "givenName": "Frederic", 
        "id": "sg:person.01046211643.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046211643.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Division of adult oncology, Oscar Lambret Institute, Lille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Penel", 
        "givenName": "Nicolas", 
        "id": "sg:person.0677574257.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677574257.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital de la Timone", 
          "id": "https://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Aix Marseille Univ, INSERM, U911, Marseille, France", 
            "Department of Medicine, Division of adult oncology, APHM, Timone Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salas", 
        "givenName": "Sebastien", 
        "id": "sg:person.0601021000.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601021000.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1530/eje-08-0648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006092842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm483", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006370749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2265.2008.03253.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013653892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hys076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015675456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14653240802317639", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019189330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molmed.2010.02.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025280461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molmed.2005.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029510803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.clpt.2005.06.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031235907", 
          "https://doi.org/10.1016/j.clpt.2005.06.010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000337086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033631373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2007-0586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036876446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa075853", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039978290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-012-9683-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047428945", 
          "https://doi.org/10.1007/s12020-012-9683-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djk008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047892911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urolonc.2009.08.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048723986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2010.0070", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059320792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2010.0234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059320861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2010.0251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059320869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2012.0378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059321511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2015.0170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059322048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2007-0649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064289967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-145-9-200611070-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073709000"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: While hypothyroidism has frequently been reported with the use of TKIs, the thyroid-stimulating hormone (TSH) suppressing effect of TKIs is rare, except for thyroiditis. We describe a case with progressive recurrent chordoma who initially became hyperthyroid in a context of autoimmunity under sorafenib treatment and later under imatinib treatment.\nCASE PRESENTATION: A 57-year-old man with lumbar chordoma began daily treatment of 800\u00a0mg sorafenib. He did not have any other medication or recent iodinated-contrast exposure and his family history was negative for thyroid and autoimmune disease. There was no history of neck pain, irradiation or trauma, recent fever or viral illness. Pre-treatment TSH was normal. After 18\u00a0weeks of treatment, the patient presented hyperthyroidism with positive anti-TSH receptor antibodies. More surprisingly, Graves' disease recurred during treatment with imatinib.\nCONCLUSION: The fact that Graves' disease occurred after two different TKIs suggests that it could be a rare but important class effect. Anti-TSH receptor antibodies should be systematically measured when TSH decreases in order to avoid the erroneous diagnosis of transient hyperthyroidism due to thyroiditis.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-016-2705-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma", 
    "pagination": "679", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "31e511acfc365bfca268bf88db7e640c7c0466c44b432b766e82f7901565597a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27558389"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-016-2705-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010473172"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-016-2705-3", 
      "https://app.dimensions.ai/details/publication/pub.1010473172"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87119_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-016-2705-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      62 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-016-2705-3 schema:about N1c7361f06cf44fd3bca476be77012167
2 N4085cb54dec2409cbc7c0759b371ce73
3 N948a79fa5f1b430385fab7dd17e79129
4 Na5acb4c2c97842ad801feae6c0e33539
5 Nb83cf264b78043fda087d88d3efa558d
6 Nc487feeabd8b4e9993f41b586b1e4fee
7 Ncbfc3165cf284fe7a805c56619358bad
8 Nda7951b259ed4cb19f080e8ff15ab667
9 Ndd4989966407413e9069f17ca5633461
10 Nf4b1c0aff524460fbf3fd225f8661e8e
11 Nf88f71c3b5b84fb6a3ade7b86dec32ad
12 Nfc1f10714d06430491fff0b1fdea1b7a
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author Nc6100f63509146fa8276bcee91e3e5b0
16 schema:citation sg:pub.10.1007/s12020-012-9683-2
17 sg:pub.10.1016/j.clpt.2005.06.010
18 https://doi.org/10.1016/j.molmed.2005.07.007
19 https://doi.org/10.1016/j.molmed.2010.02.001
20 https://doi.org/10.1016/j.urolonc.2009.08.011
21 https://doi.org/10.1056/nejmoa075853
22 https://doi.org/10.1080/14653240802317639
23 https://doi.org/10.1089/thy.2010.0070
24 https://doi.org/10.1089/thy.2010.0234
25 https://doi.org/10.1089/thy.2010.0251
26 https://doi.org/10.1089/thy.2012.0378
27 https://doi.org/10.1089/thy.2015.0170
28 https://doi.org/10.1093/annonc/mdm483
29 https://doi.org/10.1093/jjco/hys076
30 https://doi.org/10.1093/jnci/djk008
31 https://doi.org/10.1111/j.1365-2265.2008.03253.x
32 https://doi.org/10.1159/000337086
33 https://doi.org/10.1210/jc.2007-0586
34 https://doi.org/10.1210/jc.2007-0649
35 https://doi.org/10.1530/eje-08-0648
36 https://doi.org/10.7326/0003-4819-145-9-200611070-00008
37 schema:datePublished 2016-12
38 schema:datePublishedReg 2016-12-01
39 schema:description BACKGROUND: While hypothyroidism has frequently been reported with the use of TKIs, the thyroid-stimulating hormone (TSH) suppressing effect of TKIs is rare, except for thyroiditis. We describe a case with progressive recurrent chordoma who initially became hyperthyroid in a context of autoimmunity under sorafenib treatment and later under imatinib treatment. CASE PRESENTATION: A 57-year-old man with lumbar chordoma began daily treatment of 800 mg sorafenib. He did not have any other medication or recent iodinated-contrast exposure and his family history was negative for thyroid and autoimmune disease. There was no history of neck pain, irradiation or trauma, recent fever or viral illness. Pre-treatment TSH was normal. After 18 weeks of treatment, the patient presented hyperthyroidism with positive anti-TSH receptor antibodies. More surprisingly, Graves' disease recurred during treatment with imatinib. CONCLUSION: The fact that Graves' disease occurred after two different TKIs suggests that it could be a rare but important class effect. Anti-TSH receptor antibodies should be systematically measured when TSH decreases in order to avoid the erroneous diagnosis of transient hyperthyroidism due to thyroiditis.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree true
43 schema:isPartOf N0c2d7c8aa72b41b49fec7887ac1f1360
44 N6376aff08a964b1daa649fec4e56f8b9
45 sg:journal.1024632
46 schema:name Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma
47 schema:pagination 679
48 schema:productId N012a994897fc4a03a7ec60f6c9a91bc6
49 N55c3bd410413477d893953e21ea59b2d
50 N821a933ca8e141ab80cdb1d2d4dd76c4
51 Nacf74ca179f74f8184e76f57d27b2b1d
52 Nf677756cc0f94dadb63665cc5fb03ffa
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010473172
54 https://doi.org/10.1186/s12885-016-2705-3
55 schema:sdDatePublished 2019-04-11T12:27
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N93d9b64c6e1f431eb19248e4fe8248d2
58 schema:url https://link.springer.com/10.1186%2Fs12885-016-2705-3
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N012a994897fc4a03a7ec60f6c9a91bc6 schema:name pubmed_id
63 schema:value 27558389
64 rdf:type schema:PropertyValue
65 N0c2d7c8aa72b41b49fec7887ac1f1360 schema:issueNumber 1
66 rdf:type schema:PublicationIssue
67 N1c7361f06cf44fd3bca476be77012167 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Phenylurea Compounds
69 rdf:type schema:DefinedTerm
70 N4085cb54dec2409cbc7c0759b371ce73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Male
72 rdf:type schema:DefinedTerm
73 N55c3bd410413477d893953e21ea59b2d schema:name nlm_unique_id
74 schema:value 100967800
75 rdf:type schema:PropertyValue
76 N6376aff08a964b1daa649fec4e56f8b9 schema:volumeNumber 16
77 rdf:type schema:PublicationVolume
78 N694b687861ae4edeb0e30db528963b22 rdf:first sg:person.01046211643.17
79 rdf:rest Nd6b08cf5791f4dbab750e6b1621ee37e
80 N821a933ca8e141ab80cdb1d2d4dd76c4 schema:name readcube_id
81 schema:value 31e511acfc365bfca268bf88db7e640c7c0466c44b432b766e82f7901565597a
82 rdf:type schema:PropertyValue
83 N93d9b64c6e1f431eb19248e4fe8248d2 schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 N948a79fa5f1b430385fab7dd17e79129 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Protein Kinase Inhibitors
87 rdf:type schema:DefinedTerm
88 Na5acb4c2c97842ad801feae6c0e33539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Neoplasm Recurrence, Local
90 rdf:type schema:DefinedTerm
91 Nacf74ca179f74f8184e76f57d27b2b1d schema:name dimensions_id
92 schema:value pub.1010473172
93 rdf:type schema:PropertyValue
94 Nb83cf264b78043fda087d88d3efa558d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Humans
96 rdf:type schema:DefinedTerm
97 Nbec9efc5e4294260974afe0e06263b2a schema:name Department of Medicine, Division of adult oncology, Oscar Lambret Institute, Lille, France
98 rdf:type schema:Organization
99 Nbf77144030e1415582777ee67421a27e rdf:first sg:person.0601021000.78
100 rdf:rest rdf:nil
101 Nc487feeabd8b4e9993f41b586b1e4fee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Chordoma
103 rdf:type schema:DefinedTerm
104 Nc6100f63509146fa8276bcee91e3e5b0 rdf:first sg:person.016217422035.81
105 rdf:rest N694b687861ae4edeb0e30db528963b22
106 Ncbfc3165cf284fe7a805c56619358bad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Imatinib Mesylate
108 rdf:type schema:DefinedTerm
109 Nd6b08cf5791f4dbab750e6b1621ee37e rdf:first sg:person.0677574257.10
110 rdf:rest Nbf77144030e1415582777ee67421a27e
111 Nda7951b259ed4cb19f080e8ff15ab667 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Middle Aged
113 rdf:type schema:DefinedTerm
114 Ndd4989966407413e9069f17ca5633461 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Sorafenib
116 rdf:type schema:DefinedTerm
117 Nf4b1c0aff524460fbf3fd225f8661e8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Graves Disease
119 rdf:type schema:DefinedTerm
120 Nf677756cc0f94dadb63665cc5fb03ffa schema:name doi
121 schema:value 10.1186/s12885-016-2705-3
122 rdf:type schema:PropertyValue
123 Nf88f71c3b5b84fb6a3ade7b86dec32ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Antineoplastic Agents
125 rdf:type schema:DefinedTerm
126 Nfc1f10714d06430491fff0b1fdea1b7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Niacinamide
128 rdf:type schema:DefinedTerm
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
133 schema:name Clinical Sciences
134 rdf:type schema:DefinedTerm
135 sg:journal.1024632 schema:issn 1471-2407
136 schema:name BMC Cancer
137 rdf:type schema:Periodical
138 sg:person.01046211643.17 schema:affiliation https://www.grid.ac/institutes/grid.411535.7
139 schema:familyName Castinetti
140 schema:givenName Frederic
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046211643.17
142 rdf:type schema:Person
143 sg:person.016217422035.81 schema:affiliation https://www.grid.ac/institutes/grid.411535.7
144 schema:familyName Eroukhmanoff
145 schema:givenName Juliette
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016217422035.81
147 rdf:type schema:Person
148 sg:person.0601021000.78 schema:affiliation https://www.grid.ac/institutes/grid.411266.6
149 schema:familyName Salas
150 schema:givenName Sebastien
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601021000.78
152 rdf:type schema:Person
153 sg:person.0677574257.10 schema:affiliation Nbec9efc5e4294260974afe0e06263b2a
154 schema:familyName Penel
155 schema:givenName Nicolas
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677574257.10
157 rdf:type schema:Person
158 sg:pub.10.1007/s12020-012-9683-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047428945
159 https://doi.org/10.1007/s12020-012-9683-2
160 rdf:type schema:CreativeWork
161 sg:pub.10.1016/j.clpt.2005.06.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031235907
162 https://doi.org/10.1016/j.clpt.2005.06.010
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.molmed.2005.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029510803
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/j.molmed.2010.02.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025280461
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/j.urolonc.2009.08.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048723986
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1056/nejmoa075853 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039978290
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1080/14653240802317639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019189330
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1089/thy.2010.0070 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059320792
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1089/thy.2010.0234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059320861
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1089/thy.2010.0251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059320869
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1089/thy.2012.0378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059321511
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1089/thy.2015.0170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059322048
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1093/annonc/mdm483 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006370749
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1093/jjco/hys076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015675456
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1093/jnci/djk008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047892911
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1111/j.1365-2265.2008.03253.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013653892
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1159/000337086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033631373
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1210/jc.2007-0586 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036876446
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1210/jc.2007-0649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064289967
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1530/eje-08-0648 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006092842
199 rdf:type schema:CreativeWork
200 https://doi.org/10.7326/0003-4819-145-9-200611070-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073709000
201 rdf:type schema:CreativeWork
202 https://www.grid.ac/institutes/grid.411266.6 schema:alternateName Hôpital de la Timone
203 schema:name Aix Marseille Univ, INSERM, U911, Marseille, France
204 Department of Medicine, Division of adult oncology, APHM, Timone Hospital, Marseille, France
205 rdf:type schema:Organization
206 https://www.grid.ac/institutes/grid.411535.7 schema:alternateName Hôpital de la Conception
207 schema:name Department of Medicine, Division of endocrinology, APHM, Conception Hospital, Marseille, France
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...